Although DSM-5 diagnosis is defined through multiple behavioral criteria encompassing impaired control, social dysfunction, continued use despite harm, and tolerance or withdrawal, converging clinical and preclinical evidence indicates that the core pathological feature of SUDs is the progressive loss of control over intake (O'Brien, 2005)
He was diagnosed and treated for type 2 diabetes mellitus and hypertension at our facility 2 years before the current presentation, with a documented baseline blood pressure of 200/110 mmHg
p = 0.002), and 11.8 kg (95% CI 17.4, -6.2
Seat depth, armrest height, and overall chair dimensions all affect spinal health
Lifestyle and Metabolic Barriers to Continued Weight Loss Sleep deprivation sabotages semaglutide effectiveness by raising cortisol and ghrelin (hunger hormone) levels, even while the medication suppresses appetite signals
Prevention or delay of type 2 diabetes and associated comorbidities: Standards of care in Diabetes-2023